Eurosurveillance banner


On 17 April 2008, Eurosurveillance is publishing a special issue with articles on the measles situation in Europe. The publication is linked to European Immunisation Week which runs from 21-27 April.

World Tuberculosis Day on 24 March commemorates the date in 1882 when Robert Koch presented his findings of the causing agent of tuberculosis (TB) – Mycobacterium tuberculosis. In the run up of this day Eurosurveillance publishes a special issue on the situation of TB in Europe.


In this issue


Home Eurosurveillance Monthly Release  2004: Volume 9/ Issue 12 Article 14 Printer friendly version
Back to Table of Contents
en es fr
Previous Next

Eurosurveillance, Volume 9, Issue 12, 01 December 2004
Guidelines
Bichat guidelines for the clinical management of tularaemia and bioterrorism-related tularaemia

Citation style for this article: Bossi P, Tegnell A, Baka A, van Loock F, Werner A, Hendriks J, Maidhof H, Gouvras G. Bichat guidelines for the clinical management of tularaemia and bioterrorism-related tularaemia. Euro Surveill. 2004;9(12):pii=503. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=503

 

Philippe Bossi*, Anders Tegnell, Agoritsa Baka, Frank Van Loock, Jan Hendriks, Albrecht Werner, Heinrich Maidhof, Georgios Gouvras

Task Force on Biological and Chemical Agent Threats, Public Health Directorate, European Commission, Luxembourg

*Corresponding author: P. Bossi, Pitié-Salpêtrière Hospital, Paris, France, email: philippe.bossi@psl.ap-hop-paris.fr

 


Francisella tularensis is one of the most infectious pathogenic bacteria known, requiring inoculation or inhalation of as few as 10 organisms to initiate human infection. Inhalational tularaemia following intentional release of a virulent strain of F. tularensis would have great impact and cause high morbidity and mortality. Another route of contamination in a deliberate release could be contamination of water.
Seven clinical forms, according to route of inoculation (skin, mucous membranes, gastrointestinal tract, eyes, respiratory tract), dose of the inoculum and virulence of the organism (types A or B) are identified. The pneumonic form of the disease is the most likely form of the disease should this bacterium be used as a bioterrorism agent. Streptomycin and gentamicin are currently considered the treatment of choice for tularemia. Quinolone is an effective alternative drug. No isolation measures for patients with pneumonia are necessary. Streptomycin, gentamicin, doxycycline or ciprofloxacin are recommended for post-exposure prophylaxis.


 
The full article is available in Pdf format

 

 



Back to Table of Contents
en es fr
Previous Next

Disclamer:The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the Editorial team or the institutions with which the authors are affiliated. Neither the ECDC nor any person acting on behalf of the ECDC is responsible for the use which might be made of the information in this journal.
Eurosurveillance [ISSN] - ©2008 All rights reserved